Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Jun Qi
Myeloma
Simona Colla
Myeloma biology
Paul Beavis
immunotherapy in myeloma
Jianhua Yu
myeloma immunotherapy
Eugenio Morelli
Myeloma
Nizar Bahlis
Myeloma immunotherapy
Sigurður Kristinsson
Smoldering myeloma
Christopher Flowers
clinical trial access
Gareth Morgan
smoldering myeloma, MGUS
Jing Yang
Myeloma
Peter Croucher
Multiple Myeloma
Ricky Johnstone
lymphoma and myeloma
Carl June
CAR T immunotherapy
Bruno Paiva
smoldering myeloma
Noemí Puig Morón
Myeloma
Tanya Siddiqi
clinical trial access
Alec Zhang
myeloma, immunotherapy
Ruben Carrasco
Myeloma
Michaela Reagan
Multiple Myeloma
Urvi Shah
Diet and myeloma
Sham Mailankody
Myeloma immunotherapy clinical trials
Lawrence Boise
CART and myeloma
Fenghuang Zhan
Myeloma and bone disease
Jonathan Licht
DNA biology, myeloma
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
John Leonard
lymphoma research
William Matsui
Myeloma
Mala Shanmugam
myeloma
Suzanne Lentzsch
Myeloma
Brian Walker
smoldering myeloma, MGUS
Alfred Garfall
myeloma immunotherapy
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
F. Lennie Wong
Equity in Access
Jing Fu
myeloma
Amin Sobh
Myeloma biology
Lev Kats
myeloma and epigenetics
Armin Rashidi
gut bacteria and transplant success
Caroline Arber
myeloma CAR-T
Qing Yi
Novel CAR-T
Matteo Bellone
Smoldering multiple myeloma
Siegfried Janz
Myeloma immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Robert Orlowski
(Smoldering) Multiple Myeloma